2026 brings significant changes to Medicare, Medicare Advantage, and ACA marketplace coverage—changes that will directly impact your clients’ costs, coverage options, and financial planning. As a licensed insurance agent, understanding these regulatory updates is essential for providing accurate guidance and identifying new client opportunities. From higher premiums to negotiated drug prices to the expiration of enhanced subsidies, the insurance landscape is shifting in ways that require your immediate attention.idence.
Medicare Part A and Part B: Higher Costs Across the Board
The Centers for Medicare & Medicaid Services (CMS) released 2026 premium and deductible amounts on November 14, 2025, and the news for beneficiaries is clear: costs are rising.
The Medicare Part B standard monthly premium will increase to $202.90 in 2026, up $17.90 from $185.00 in 2025. This represents a 9.7% increase that will affect all Medicare beneficiaries not receiving premium-free Part B coverage. The Part B annual deductible also increases to $283, up $26 from $257 in 2025.
For Part A, the inpatient hospital deductible rises to $1,736 in 2026, an increase of $60 from 2025. Daily coinsurance amounts for extended hospital stays and skilled nursing facility care also increase substantially. These increases reflect projected price changes and utilization increases consistent with historical trends.
What this means for your clients: Medicare beneficiaries will face higher out-of-pocket costs regardless of whether they choose Original Medicare or Medicare Advantage. This creates an excellent opportunity to discuss supplemental coverage options, including Medigap policies and Medicare Advantage plans with enhanced benefits.
Medicare Advantage: Premiums Down, But Enrollment Disruption Up
While Medicare Advantage (Part C) premiums are decreasing to an average of $14.00 per month in 2026—down from $16.40 in 2025—the picture is more complicated for beneficiaries. The maximum out-of-pocket limit for in-network services decreases to $9,250, down from $9,350 in 2025, which is positive news for cost-conscious enrollees.
However, approximately 2.9 million Medicare Advantage enrollees are facing forced disenrollment in 2026 following a sharp rise in insurers exiting specific markets. This represents a significant disruption that will require your intervention to help affected clients transition to new coverage.
The good news: over 99% of Medicare beneficiaries continue to have access to at least one Medicare Advantage plan, and enrollment has grown to over 35 million people. Additionally, the Medicare Plan Finder now includes integrated provider directory information for the first time, making it easier for beneficiaries to verify their doctors are in-network before enrolling.
What this means for your clients: Forced disenrollments create urgent client service opportunities. Beneficiaries affected by plan exits need immediate guidance on alternative coverage options. The enhanced Plan Finder also means clients can make more informed decisions, reducing post-enrollment complaints about provider networks.
Part D: Negotiated Drug Prices and Rising Caps
Prescription drug coverage is undergoing significant changes in 2026. The out-of-pocket spending cap for Part D plans increases to $2,100, up from $2,000 in 2025, while the maximum deductible rises to $615, up from $590.
The more exciting news involves Medicare’s drug price negotiation program. Beginning January 1, 2026, 10 prescription drugs with high costs for Medicare are available at lower prices negotiated directly by CMS. These medications include treatments for arthritis, blood clots, cancer, and diabetes. The savings are substantial: beneficiaries are expected to save approximately $1.5 billion in out-of-pocket costs in 2026 alone.
An additional 15 drugs will be negotiated for 2027, with prices effective January 1, 2027. This represents a fundamental shift in how Medicare addresses prescription drug affordability.
What this means for your clients: Clients taking any of the 10 negotiated drugs should immediately review their Part D plans to ensure they’re enrolled in a plan that covers these medications at the negotiated prices. This is a concrete way to demonstrate value and reduce client out-of-pocket costs.
GLP-1 Weight-Loss Medications: New Coverage Starting July 2026
In a significant development, Medicare will begin covering popular GLP-1 weight-loss medications—including Mounjaro, Ozempic, Wegovy, and Zepbound—starting in July 2026. This represents the first time Medicare has covered these medications for weight management.
Beneficiaries with a body mass index (BMI) of 35 or higher will be eligible without requiring a preexisting condition diagnosis. Those with a BMI of 27 or higher can qualify if they have prediabetes or cardiovascular disease. The monthly cost will be capped at $50 for eligible beneficiaries.
This coverage begins as a six-month bridge program, with a full obesity management pilot launching in 2027. Beneficiaries won’t need to meet their deductible before accessing these medications through the bridge program.
What this means for your clients: This is a major selling point for Medicare Advantage and Part D plans. Clients interested in weight management now have access to these medications at an affordable cost, which can improve overall health outcomes and reduce future medical expenses.
ACA Marketplace: Subsidy Expiration and Premium Shock
The most significant change for ACA marketplace enrollees is the expiration of enhanced premium tax credits on December 31, 2025. These enhanced subsidies, implemented through the American Rescue Plan, have provided substantial financial assistance to millions of Americans for five years.
As of January 1, 2026, these enhancements are gone. The subsidy rules have reverted to pre-2021 levels, meaning subsidies cover less of premiums, and the “subsidy cliff” has returned. Individuals earning more than 400% of the federal poverty level are no longer eligible for any subsidies.
The impact is dramatic: ACA marketplace premiums have increased by approximately 20% on average for 2026, with benchmark premiums rising 21.7%. Approximately 22 million people who received enhanced subsidies are now facing significantly higher monthly costs.
However, several states have stepped in with their own subsidies to offset the federal reduction. California, Colorado, Connecticut, Maryland, Massachusetts, and New Mexico have all enhanced their state-funded subsidies for 2026.
What this means for your clients: ACA marketplace clients need immediate attention. Many will face substantial premium increases and may need to switch plans to find more affordable options. Some may qualify for special enrollment periods if they experience qualifying life events. Agents should proactively reach out to marketplace clients to discuss their 2026 options before they face unexpected premium bills.
Additional Marketplace Changes: HSA Expansion and APTC Reconciliation
Starting in 2026, all Bronze and Catastrophic plans purchased through the ACA marketplace are now HSA-eligible. This represents a significant expansion from prior years, when only a small fraction of Bronze plans qualified.
Additionally, the cap on repayment of excess advance premium tax credits (APTC) has been eliminated. Beginning with the 2026 plan year, any excess APTC paid must be fully reconciled when beneficiaries file their taxes, regardless of income level. This creates additional risk for beneficiaries who overestimate their income.
Your Action Plan for 2026
These changes create multiple opportunities for agent engagement. Schedule proactive reviews with Medicare clients to discuss premium increases and coverage options. Reach out to Medicare Advantage clients who may be affected by plan exits. Contact ACA marketplace clients about subsidy changes and plan options. Educate clients about negotiated drug prices and new GLP-1 coverage. And consider expanding your practice to include HSA-eligible marketplace plans for health-conscious clients.
The insurance landscape is changing rapidly in 2026. Your clients depend on you to navigate these changes successfully.
